| Medical and Health Sciences | Lifetime | 120 | US 68 | 99.99 |
| Cardiology and Cardiovascular Medicine | Lifetime | 13 | US 10 | 99.99 |
| Genetics | Lifetime | 527 | US 281 | 98.78 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 639 | US 356 | 98.33 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 654 | US 345 | 97.83 |
| Complementary and Alternative Medicine | Lifetime | 515 | US 188 | 96.57 |
| Nephrology | Lifetime | 684 | US 317 | 90.89 |
| Genetics | 2021-2025 | 115 | US 47 | 97.19 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 671 | US 291 | 87.95 |
| Cardiovascular Function and Risk Factors | Lifetime | 3 | US 3 | 99.99 |
| Cardiovascular Disease and Adiposity | Lifetime | 2 | US 2 | 99.96 |
| Blood Pressure and Hypertension Studies | Lifetime | 8 | US 3 | 99.93 |
| Cardiovascular Health and Disease Prevention | Lifetime | 18 | US 6 | 99.81 |
| Cardiovascular Health and Risk Factors | Lifetime | 10 | US 7 | 99.75 |
| Heart Rate Variability and Autonomic Control | Lifetime | 48 | US 22 | 99.68 |
| Heart Failure Treatment and Management | Lifetime | 58 | US 36 | 99.76 |
| Cardiac Imaging and Diagnostics | Lifetime | 177 | US 99 | 99.68 |
| Genetic Associations and Epidemiology | Lifetime | 92 | US 44 | 99.32 |
| Hormonal Regulation and Hypertension | Lifetime | 169 | US 70 | 99.05 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 270 | US 119 | 99.27 |
| Cardiac electrophysiology and arrhythmias | Lifetime | 317 | US 172 | 99.08 |
| Epigenetics and DNA Methylation | Lifetime | 732 | US 386 | 98.32 |
| Birth, Development, and Health | Lifetime | 677 | US 261 | 98.15 |
| Sodium Intake and Health | Lifetime | 97 | US 45 | 98.28 |
| Drug Transport and Resistance Mechanisms | Lifetime | 518 | US 209 | 97.79 |
| Cardiac pacing and defibrillation studies | Lifetime | 592 | US 307 | 98.27 |
| Cardiovascular Effects of Exercise | Lifetime | 454 | US 201 | 97.44 |
| Cardiovascular and exercise physiology | Lifetime | 564 | US 214 | 97.70 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 695 | US 288 | 97.78 |
| ECG Monitoring and Analysis | Lifetime | 304 | US 116 | 96.88 |
| Cardiomyopathy and Myosin Studies | Lifetime | 644 | US 321 | 96.97 |
| Alcohol Consumption and Health Effects | Lifetime | 591 | US 288 | 96.17 |
| Lipoproteins and Cardiovascular Health | Lifetime | 923 | US 374 | 96.60 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 967 | US 372 | 96.25 |
| T-cell and Retrovirus Studies | Lifetime | 517 | US 243 | 95.64 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 983 | US 445 | 95.87 |
| Chronic Kidney Disease and Diabetes | Lifetime | 869 | US 348 | 95.57 |
| Heart rate and cardiovascular health | Lifetime | 88 | US 37 | 93.89 |
| Telomeres, Telomerase, and Senescence | Lifetime | 606 | US 250 | 91.80 |
| GDF15 and Related Biomarkers | Lifetime | 276 | US 101 | 87.88 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 927 | US 254 | 87.26 |
| Sex and Gender in Healthcare | Lifetime | 870 | US 439 | 69.56 |
| Epigenetics and DNA Methylation | 2021-2025 | 118 | US 43 | 97.33 |
| Genetic Associations and Epidemiology | 2021-2025 | 244 | US 103 | 94.93 |
| Birth, Development, and Health | 2021-2025 | 489 | US 165 | 93.30 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 182 | US 97 | 92.34 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 654 | US 159 | 85.10 |
| GDF15 and Related Biomarkers | 2021-2025 | 159 | US 48 | 76.66 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 952 | US 186 | 75.45 |
| Genetic Syndromes and Imprinting | 2021-2025 | 484 | US 144 | 72.15 |
